For the first time, click chemistry — a Nobel-recognized technology — has been used clinically to direct chemotherapy agents specifically to tumors, minimizing systemic toxicity. This bio-orthogonal approach allows drugs to be activated selectively at cancer sites, representing a significant advance in targeted cancer treatments. The study demonstrates the clinical safety and therapeutic potential of this chemical strategy, highlighting a promising platform for future oncology interventions.